机构：[1]Center for Immunology and Hematology, Department of Biotherapy and Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[2]Chongqing International Institute for Immunology, Chongqing 401338, China[3]Shanghai Chest Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai 200025, China
Chongqing International Institute for Immunology (2020YJC01), National Natural Science Foundation of China (82025002 and 32230036),
the 1.3.5 Project of disciplines of excellence (ZYGD22005), West China
Hospital, Sichuan University.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|1 区医学
小类|2 区肿瘤学
最新[2023]版：
大类|1 区医学
小类|2 区肿瘤学
第一作者：
第一作者机构：[1]Center for Immunology and Hematology, Department of Biotherapy and Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China[2]Chongqing International Institute for Immunology, Chongqing 401338, China[3]Shanghai Chest Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai 200025, China
推荐引用方式(GB/T 7714)：
Hu Hongbo.Editorial: The progress and challenges of hematological malignancies in the era of big data and new therapy[J].Cancer letters.2023,216399.doi:10.1016/j.canlet.2023.216399.
APA：
Hu Hongbo.(2023).Editorial: The progress and challenges of hematological malignancies in the era of big data and new therapy.Cancer letters,,
MLA：
Hu Hongbo."Editorial: The progress and challenges of hematological malignancies in the era of big data and new therapy".Cancer letters .(2023):216399
医学